calendar
4,004 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 98 grant
4,004 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 98 grant
Sponsor: National Institute on Drug Abuse (NIDA). Phase: NA. Conditions: Major Depressive Disorder, Substance Use Disorder, Normal Physiology
Sponsor: International Extranodal Lymphoma Study Group (IELSG). Phase: PHASE2. Conditions: Marginal Zone Lymphoma of Ocular Adnexal
Sponsor: Stanford University. Phase: PHASE1. Conditions: Glioma of Spinal Cord, Glioma of Brainstem
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE1. Conditions: Gastric Cancer, Esophageal Cancer, GastroEsophageal Cancer
Sponsor: Colorado State University. Phase: NA. Conditions: Perceived Stress, State Anxiety, Intrinsic Goal Orientation, Study Habits, Mood, Sleep Quality, Connectedness to Nature, Extrinsic Goal Orientation
Sponsor: KU Leuven. Phase: NA. Conditions: IBS, Healthy
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: NA. Conditions: Severe Acute Respiratory Infection
Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Misophonia
Sponsor: Abramson Cancer Center at Penn Medicine. Phase: . Conditions: Cancer
Sponsor: Axon Therapies, Inc.. Phase: NA. Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF)
Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Melanoma, Renal Cell Carcinoma
Sponsor: University of Santiago de Compostela. Phase: EARLY_PHASE1. Conditions: Regeneration, Periodontal Defects, Biomaterials
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: PHASE1. Conditions: Pertussis, Whooping Cough
Sponsor: Biocon Biologics UK PLC. Phase: PHASE1. Conditions: Healthy Male Participants
Sponsor: University of Illinois at Chicago. Phase: PHASE1. Conditions: Relapsed or Refractory Hematologic Malignancies
Sponsor: Yi Tian. Phase: PHASE1. Conditions: Tumor, Metastatic Cancer
Sponsor: BeiGene. Phase: PHASE1. Conditions: Advanced Solid Tumor
Sponsor: Feng Gao. Phase: NA. Conditions: Vertebrobasilar Artery Occlusion, Endovascular Treatment
Sponsor: Rebecca Price. Phase: PHASE4. Conditions: Suicide, Attempted
Sponsor: Genentech, Inc.. Phase: PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: NA. Conditions: Neurodevelopmental Disorders
Sponsor: University of Oregon. Phase: NA. Conditions: Smoking Cessation, Smoking Reduction, Cancer
Sponsor: [Redacted]. Phase: . Conditions:
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Sponsor: Tokyo University. Phase: NA. Conditions: Cognition Disorders in Old Age, Cognitive Function, Frailty/Sarcopenia, MCI
Sponsor: Impact Therapeutics, Inc.. Phase: PHASE2. Conditions: Ovarian Cancer
Sponsor: Duke University. Phase: PHASE3. Conditions: Agitated Delirium, Delirium Confusional State, Delirium in the Intensive Care Unit, Hyperactive Delirium
Sponsor: City of Hope Medical Center. Phase: EARLY_PHASE1. Conditions: Stage 3 Type 1 Diabetes
Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Obsessive-Compulsive Disorder in Children, Anxiety Disorder of Childhood, Social Anxiety Disorder of Childhood, Obsessive-Compulsive Disorder in Adolescence, Generalized Anxiety Disorder, Separation Anxiety, Panic Disorder, Panic Disorder With Agoraphobia, Panic Attacks
Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Occupational Exposure
Sponsor: Hospices Civils de Lyon. Phase: PHASE2. Conditions: Arrhythmogenic Right Ventricular Dysplasia
Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: . Conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Carbapenem-resistant Enterobacterales
Sponsor: Heinrich-Heine University, Duesseldorf. Phase: . Conditions: Multiple Sclerosis, Remitting-Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progress Multiple Sclerosis, Fatigue Syndrome, Chronic, Sleep Disorders
Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Opioid Use Disorder
Sponsor: Abdelrahman Mahmoud. Phase: PHASE2. Conditions: Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus)
Sponsor: Shenzhen Geno-Immune Medical Institute. Phase: PHASE1. Conditions: Autoimmune Diseases
Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Positive Pressure Ventilation
Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Cancer Survivorship
Sponsor: National and Kapodistrian University of Athens. Phase: . Conditions: Chronic Rhinosinusitis With Nasal Polyps, Severe Eosinophilic Asthma, Chronic Rhinosinusitis Without Nasal Polyps
Sponsor: CathVision ApS. Phase: . Conditions: Atrial Fibrillation (AF)
Sponsor: Kessler Foundation. Phase: NA. Conditions: Stroke, Chronic Stroke Patients
Sponsor: Evopoint Biosciences Inc.. Phase: PHASE1. Conditions: Advanced Tumor, Lymphoma
Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Type 2 Diabetes Mellitus
Sponsor: Acibadem University. Phase: NA. Conditions: Dysmenorrhea, Primary Dysmenorrhea
Sponsor: Johns Hopkins University. Phase: PHASE4. Conditions: Multiple Sclerosis
Sponsor: Subha Subramanian. Phase: NA. Conditions: Major Depressive Disorder (MDD)
Sponsor: University of Maryland, Baltimore. Phase: NA. Conditions: Traumatic Brain Injury
Sponsor: University Hospital, Rouen. Phase: . Conditions: Urinary Tract Infection Empiric Antibiotic
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Head and Neck Carcinoma
Sponsor: Société des Produits Nestlé (SPN). Phase: NA. Conditions: Cerebral Palsy (CP), Oncology